Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhiling Pharmaceutical Group is a specialized pharmaceutical company based in Shenzhen, China, primarily focused on oncology and the integration of Traditional Chinese Medicine (TCM) with Western medical practices. The company is best known for its flagship product, Zhiling Capsule, which is an approved anti-tumor therapy used to treat various malignant stages of cancer and alleviate symptoms associated with chemotherapy and radiotherapy. Zhiling Pharmaceutical operates modern manufacturing facilities that adhere to national GMP standards and emphasizes the modernization of TCM through clinical research. The company's products are widely distributed across China, aiming to improve the survival rates and quality of life for cancer patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhiling Pharmaceutical Group.